Cytosorbents Corp
CTSO
102 hedge funds and large institutions have $132M invested in Cytosorbents Corp in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 38 reducing their positions, and 11 closing their positions.
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
6% more funds holding
Funds holding: 96 → 102 (+6)
0.07% more ownership
Funds ownership: 40.39% → 40.46% (+0.07%)
13% less capital invested
Capital invested by funds: $152M → $132M (-$19.2M)
31% less call options, than puts
Call options by funds: $1.03M | Put options by funds: $1.49M
34% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$8.49M |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$1.64M |
| 3 |
MGIM
M&G Investment Management
London,
United Kingdom
|
+$1.27M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$770K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$608K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$6.94M |
| 2 |
BlackRock
New York
|
-$1.58M |
| 3 |
AIC
AWM Investment Company
New York
|
-$1.3M |
| 4 |
WAS
Wealth Advisory Solutions
Indiianapolis,
Indiana
|
-$1.2M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.11M |
CTSO Hedge Fund Activity: Q2 2021 in Review
102 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2021, worth a combined $132M — down 13% from $152M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CTSO positions and 11 closed out — a net gain of 6 holders — while 25 added to existing stakes and 38 trimmed.
The largest buyer was Avenir Corporation, adding an estimated $8.49M. The largest seller was Redmile Group, cutting an estimated $6.94M.
- 102 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2021, up from 96 in Q1 2021.
- Funds reported $132M of Cytosorbents Corp stock for Q2 2021, down 13% quarter-over-quarter.
- 17 funds opened new Cytosorbents Corp positions in Q2 2021 and 11 closed out, a net change of +6 holders.
- The largest Cytosorbents Corp buyer in Q2 2021 was Avenir Corporation, an estimated $8.49M added.
- The largest Cytosorbents Corp seller in Q2 2021 was Redmile Group, an estimated $6.94M sold.
Based on aggregated 13F filings for Q2 2021.